Immediate Impact
8 from Science/Nature 66 standout
Citing Papers
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
CAR T-cell therapy in autoimmune diseases
2023 Standout
Works of Lawrence D. Durack being referenced
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.
2004
Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lawrence D. Durack | 745 | 709 | 238 | 441 | 18 | 1.2k | |
| Christopher C. Badger | 947 | 449 | 225 | 365 | 25 | 1.3k | |
| Mars B. van ’t Veer | 241 | 524 | 193 | 350 | 36 | 1.4k | |
| Judith Estes | 934 | 880 | 334 | 455 | 10 | 1.4k | |
| Leslie E. Botnick | 194 | 593 | 150 | 483 | 31 | 1.6k | |
| Denise Regan | 1165 | 925 | 388 | 469 | 13 | 1.6k | |
| Mehmet F. Fer | 394 | 313 | 126 | 404 | 22 | 1.1k | |
| Christine De Wolf‐Peeters | 501 | 855 | 360 | 387 | 11 | 1.2k | |
| SA Rosenberg | 225 | 751 | 362 | 587 | 28 | 1.7k | |
| Max S. Topp | 285 | 471 | 141 | 779 | 35 | 1.2k | |
| Martina Chiarucci | 279 | 1232 | 218 | 890 | 10 | 1.7k |
All Works
Loading papers...